Researchers highlight gaps in disclosure of payments between radiologists and AI device manufacturers, urging greater transparency to ensure ethical AI deployment.
Key Details
- 1Many AI-enabled radiology devices have been FDA cleared in the past decade.
- 2Researchers found that over 90% of these device manufacturers reported zero payments to healthcare professionals or teaching hospitals (2017–2023).
- 3This is attributed to regulatory gaps and ambiguities in AI device classification and reporting requirements.
- 4Recent commenters on FDA AI regulations often failed to disclose industry ties.
Why It Matters
As AI becomes more integral to radiology, undisclosed relationships between clinicians and developers could bias research, product adoption, and regulatory processes. Strengthening transparency safeguards patient trust and ensures objective evaluation of new technologies.
Source
Radiology Business
Related News
•AuntMinnie
AI-Enhanced Chest X-rays Improve COPD Mortality Prediction
An open-source AI model using chest x-rays accurately predicts respiratory mortality in COPD patients, outperforming standard clinical risk grading.
•Radiology Business
Rayus Radiology Launches $40 AI Mammography Screenings in Washington
Rayus Radiology is introducing a $40 AI-enhanced mammography add-on service at clinics in Washington state.
•AuntMinnie
AI-CAD Demonstrates High Sensitivity in Breast Cancer Screening
A large study found that AI-based computer-aided detection (AI-CAD) can improve breast cancer detection and support radiologists in screening mammography.